Safety Study of Erythropoietin (EPO) in Parkinson's Disease

NCT01010802 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: Erythropoietin human recombinant (EPOrh)

Sponsor

International Center for Neurological Restoration, Cuba

Collaborators

[object Object]